276 related articles for article (PubMed ID: 27886397)
21. Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas.
Ye J; Qi Y; Wang W; Sun F; Wei Q; Su T; Zhou W; Jiang Y; Yuan W; Cai J; Cui B; Ning G
Endocrine; 2012 Jun; 41(3):479-86. PubMed ID: 22311173
[TBL] [Abstract][Full Text] [Related]
22. Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
Gara SK; Wang Y; Patel D; Liu-Chittenden Y; Jain M; Boufraqech M; Zhang L; Meltzer PS; Kebebew E
Nucleic Acids Res; 2015 Oct; 43(19):9327-39. PubMed ID: 26446994
[TBL] [Abstract][Full Text] [Related]
23. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
[TBL] [Abstract][Full Text] [Related]
24. Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome.
Ronchi CL; Sbiera S; Altieri B; Steinhauer S; Wild V; Bekteshi M; Kroiss M; Fassnacht M; Allolio B
Endocr Relat Cancer; 2015 Aug; 22(4):531-43. PubMed ID: 25979380
[TBL] [Abstract][Full Text] [Related]
25. An Interesting Case of Hepatic Adrenocortical Carcinoma.
Permana H; Darmawan G; Ritonga E; Kusumawati M; Miftahurachman M; Soetedjo NN
Acta Med Indones; 2018 Jul; 50(3):257-259. PubMed ID: 30333277
[TBL] [Abstract][Full Text] [Related]
26. Expression of telomerase (hTERT) in aldosterone-producing adrenocortical tumors.
Sticchi D; Fassina A; Ganzaroli C; Pasqualetto C; Pessina AC; Nussdorfer GG; Rossi GP
Int J Mol Med; 2006 Mar; 17(3):469-74. PubMed ID: 16465394
[TBL] [Abstract][Full Text] [Related]
27. [Telomerase expression in various lesions of adrenal cortex].
Mao QZ; Rong S; Fan JH; Ji ZG; Li HZ; Zang MF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):188-9. PubMed ID: 12905801
[TBL] [Abstract][Full Text] [Related]
28. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
Faillot S; Assie G
Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
[TBL] [Abstract][Full Text] [Related]
30. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
[TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas.
Sarkaria IS; Stojadinovic A; Talbot SG; Hoos A; Dudas ME; Brennan MF; Ghossein RA; Singh B
Surgery; 2004 Dec; 136(6):1122-8. PubMed ID: 15657565
[TBL] [Abstract][Full Text] [Related]
32. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G
Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
[TBL] [Abstract][Full Text] [Related]
34. Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer.
Faria AM; Sbiera S; Ribeiro TC; Soares IC; Mariani BM; Freire DS; de Sousa GR; Lerario AM; Ronchi CL; Deutschbein T; Wakamatsu A; Alves VA; Zerbini MC; Mendonca BB; Fragoso MC; Latronico AC; Fassnacht M; Almeida MQ
Clin Endocrinol (Oxf); 2015 Apr; 82(4):481-8. PubMed ID: 25200669
[TBL] [Abstract][Full Text] [Related]
35. Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival.
Waldmann J; Feldmann G; Slater EP; Langer P; Buchholz M; Ramaswamy A; Saeger W; Rothmund M; Fendrich V
Br J Cancer; 2008 Dec; 99(11):1900-7. PubMed ID: 19018264
[TBL] [Abstract][Full Text] [Related]
36. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
37. Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors.
Beuschlein F; Schulze E; Mora P; Gensheimer HP; Maser-Gluth C; Allolio B; Reincke M
J Clin Endocrinol Metab; 1998 Jul; 83(7):2585-8. PubMed ID: 9661649
[TBL] [Abstract][Full Text] [Related]
38. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma.
Yuan H; Wu Y; Wang J; Qin X; Huang Y; Yan L; Fana Y; Zedenius J; Juhlin CC; Larsson C; Lui WO; Xu D
Biomed Pharmacother; 2022 May; 149():112796. PubMed ID: 35279598
[TBL] [Abstract][Full Text] [Related]
40. Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.
de Sousa GR; Ribeiro TC; Faria AM; Mariani BM; Lerario AM; Zerbini MC; Soares IC; Wakamatsu A; Alves VA; Mendonca BB; Fragoso MC; Latronico AC; Almeida MQ
Oncotarget; 2015 Sep; 6(26):22724-33. PubMed ID: 26087193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
